Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Detection of bacterial biofilms using covalent lectin binders

07.12.2017

HIPS researchers produced a molecule that provides a way to visualise Pseudomonas infections

Pseudomonas aeruginosa is a major pathogen that can cause severe infections in various organs of the human body. The infection becomes particularly harmful when the bacteria agglomerate into biofilms: They do this not only to evade attacks of the immune system, but also to protect themselves from the effects of antibiotics. This results in chronic infections that are almost impossible to treat.


Biofilm of a clinical isolate of Pseudomonas aeruginosa stained with fluorescent dyes (green: living cells; red: dead cells)

TWINCORE/Janne Thöming

Scientists from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a joint branch of the Helmholtz Centre for Infection Research (HZI) and Saarland University, developed a molecule, which binds specifically and irreversibly to a key bacterial protein in biofilms.

By binding, this molecule blocks an important component of the biofilm and can also visualise the biofilm, when it is labelled with an appropriate dye. The scientists published their results in the international edition of Angewandte Chemie.

Bacteria of the Pseudomonas aeruginosa species are hospital germs and are resistant to many common antibiotics. They can infect all organs and implants and form so-called biofilms, in which they are protected and survive for long periods of time. This results in a chronic infection that is very difficult to treat, since both the immune system and antibiotics cannot harm the bacteria.

To produce a biofilm, Pseudomonas bacteria release certain proteins called lectins. These proteins bind to sugar molecules outside the bacterial cells and cross-link them to form a matrix, in which the pathogens agglomerate. If it was possible to block these lectins with an agent, existing biofilms could be dissolved or the production of biofilms could be prevented altogether.

Since, for instance, the lectin called "LecA" binds sugar molecules only relatively loosely, the HIPS researchers directed by Dr Alexander Titz imparted on a search for a molecule that permanently binds to LecA. This requires a so-called covalent bond or atomic bond. "Initially, we used X-ray structural analysis to analyse the three-dimensional structure of LecA and then we rationally designed a small molecule, whose properties should allow it to form a covalent bond to the sugar binding site of LecA," says Alexander Titz.

After designing this molecule, the researchers then produced it by synthesis in the laboratory and exposed it to LecA. Using a variety of biophysical methods, their collaboration partners at the HIPS and the Centre national de la recherche scientifique in Grenoble were able to prove the exact position of the binding site on the lectin. Using mass spectrometry, they were able to unequivocally demonstrate covalent binding.

"This is the first time a specific molecule was produced that binds covalently to a lectin," says Titz, who is the head of the "Chemical Biology of Carbohydrates" junior research group of the HZI and the German Center for Infection Research. One possible approach to an application is to develop the molecule into an agent that suppresses biofilm production in Pseudomonas aeruginosa.

The bacteria would then grow normally, but would no longer produce a biofilm and would be much less hazardous – since they lose their virulence. They would then be susceptible to treatment with antibiotics, if they are not eliminated earlier by the immune system. However, the new molecule still needs to be optimised more for this approach as a pathogenicity blocker.

"We already demonstrated another application, though, namely in imaging," says Alexander Titz. "We coupled the lectin-binding molecule to a fluorescent dye and were able to visualise existing biofilms." To date, a diagnosis of a Pseudomonas aeruginosa infection can be made, but the exact site of the infection in the body is often difficult to determine. As a result the therapy cannot be directed specifically at the affected organ or tissue.

"We still need to develop the molecule further for diagnostic application in humans. For example, instead of the fluorescence dye, we need to use a probe that facilitates detection by magnetic resonance or positron emission tomography," says Titz. In addition, the long-term survival of the molecule in the body needs to be assured. These optimisation processes are ongoing in the scope of funding from the European Research Council (ERC).

Original publication:
Stefanie Wagner, Dirk Hauck, Michael Hoffmann, Roman Sommer, Ines Joachim, Rolf Müller, Anne Imberty, Annabelle Varrot, Alexander Titz: Covalent lectin inhibition and application in bacterial biofilm imaging. Angewandte Chemie International Edition, 2017. DOI: 10.1002/anie.201709368

The press release and a picture are also available on our website: https://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/detection...

Helmholtz Centre for Infection Research:
Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, are engaged in the study of different mechanisms of infection and of the body’s response to infection. Helping to improve the scientific community’s understanding of a given bacterium’s or virus’ pathogenicity is key to developing effective new treatments and vaccines. http://www.helmholtz-hzi.de/en

German Center for Infection Research:
At the German Center for Infection Research (DZIF), about 500 scientists from 35 institutions nationwide jointly develop new approaches for the prevention, diagnosis and treatment of infectious diseases. Their aim is to translate research results into clinical practice rapidly and effectively. With this, the DZIF paves the way for developing new vaccines, diagnostics and drugs in the fight against infections. Further information at: http://www.dzif.de

Contact:
Susanne Thiele, Press Officer
susanne.thiele@helmholtz-hzi.de
Dr Andreas Fischer, Editor
andreas.fischer@helmholtz-hzi.de

Helmholtz Centre for Infection Research
Press and Communications
Inhoffenstr. 7
D-38124 Braunschweig
Germany

Phone: +49 531 6181-1404

Susanne Thiele | Helmholtz-Zentrum für Infektionsforschung

More articles from Life Sciences:

nachricht Cryo-EM reveals 'crown-like' structure of protein responsible for regulating blood flow
07.12.2017 | Van Andel Research Institute

nachricht New project to investigate the role of novel protein in cancer metastasis
07.12.2017 | Institute of Science and Technology Austria

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

Im Focus: Successful Mechanical Testing of Nanowires

With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong

Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...

Im Focus: Virtual Reality for Bacteria

An interdisciplinary group of researchers interfaced individual bacteria with a computer to build a hybrid bio-digital circuit - Study published in Nature Communications

Scientists at the Institute of Science and Technology Austria (IST Austria) have managed to control the behavior of individual bacteria by connecting them to a...

Im Focus: A space-time sensor for light-matter interactions

Physicists in the Laboratory for Attosecond Physics (run jointly by LMU Munich and the Max Planck Institute for Quantum Optics) have developed an attosecond electron microscope that allows them to visualize the dispersion of light in time and space, and observe the motions of electrons in atoms.

The most basic of all physical interactions in nature is that between light and matter. This interaction takes place in attosecond times (i.e. billionths of a...

Im Focus: A transistor of graphene nanoribbons

Transistors based on carbon nanostructures: what sounds like a futuristic dream could be reality in just a few years' time. An international research team working with Empa has now succeeded in producing nanotransistors from graphene ribbons that are only a few atoms wide, as reported in the current issue of the trade journal "Nature Communications."

Graphene ribbons that are only a few atoms wide, so-called graphene nanoribbons, have special electrical properties that make them promising candidates for the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

Blockchain is becoming more important in the energy market

05.12.2017 | Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

 
Latest News

A 100-fold leap to GigaDalton DNA nanotech

07.12.2017 | Information Technology

Cryo-EM reveals 'crown-like' structure of protein responsible for regulating blood flow

07.12.2017 | Life Sciences

New project to investigate the role of novel protein in cancer metastasis

07.12.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>